The Evolution Summit Announces May 2026 Program for Clinical Trial Leaders in Fort Lauderdale

Fort Lauderdale, FL (May 2026)
marcus evans announces The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida. Designed as an invitation-only, premium forum, the Summit convenes leading clinical trial executives alongside innovative suppliers and solution providers to address the operational realities and emerging opportunities reshaping clinical research and drug development.

The Evolution Summit is structured around a dynamic agenda of visionary keynote presentations, real-life case studies, and interactive forums, supported by expert moderation. The content is aligned with key industry challenges, relevant market developments, and practical strategies adopted by organizations driving measurable progress in clinical operations.

A distinguished speaker line-up reflects the breadth of perspectives required to advance trial performance and patient access. Featured participants include Craig Lipset, Co-Chair of The Decentralized Trials & Research Alliance (DTRA), bringing a forward-looking view of modern trial design and execution. The program also highlights Laura Vessey, Senior Director and Head of Early Development and Clinical Pharmacology at Johnson & Johnson Innovative Medicine, serving as a dynamic moderator. Additional senior leaders include Megan Wanzo (Bristol Myers Squibb), Asha Hope (Bayer), Kristine Koontz (Daiichi Sankyo US), Rachelle Senzon (BioNTech US Inc.), Deirdre BeVard (CSL Behring), Eileen McNulty (Imviva Biotech), Laurie Myers (Merck), Tracy Bisson (Takeda Pharmaceuticals), and Patrick Ezeh (Biogen). The Summit also features community and advocacy expertise from organizations such as CISCRP and PALADIN, as well as academic and clinical research voices including Emory University School of Medicine and Virginia iSpine Physicians/Virginia Spine Research Institute.

The 2026 agenda will explore six central themes: Successful Outcomes, focusing on best practices for trial close-out, accountability, and oversight; Optimizing Resources, addressing operational and financial countermeasures amid R&D constraints; Empowering Patients, advancing patient-centered strategies and accessibility; Proactive Engagement, strengthening partnerships through transparency to reduce barriers and accelerate execution; Leveraging Technology, examining how AI and innovative tools can improve speed, quality, and decision-making; and Strategic Alignment, assessing the future of clinical operations and drug development within an evolving regulatory landscape.

With more than 40 years of experience producing premium business events, marcus evans delivers high-quality, sector-focused forums supported by proprietary analysis of executive priorities. The organization employs 3,000 professionals across 59 worldwide locations, providing up-to-the-minute intelligence for businesses and professionals globally.

Media Contact
Stavros Karelidis, Senior Marketing Manager
Phone: 646-741-3059
Email: stavroska@marcusevanscy.com